Comparison of allelic ratios from paired blood and paraffin-embedded normal tissue for use in a polymerase chain reaction to assess loss of heterozygosity
Np. Zauber et al., Comparison of allelic ratios from paired blood and paraffin-embedded normal tissue for use in a polymerase chain reaction to assess loss of heterozygosity, MOL DIAGN, 4(1), 1999, pp. 29-35
Background: One method to assess loss of heterozygosity (LOH) of various ge
nes is the amplification of DNA from neoplastic tissue by using microsatell
ite markers. LOH can best be considered on a quantitative basis as a compar
ison of allelic ratios of neoplastic tissue to that of the normal control.
We will illustrate through quantitative methods the importance of using the
appropriate controls when determining allelic loss.
Methods and Results: DNA extracted from 28 paired blood and formalin-fu;ed,
paraffin-embedded normal mucosal tissue was amplified using the DP1 micros
atellite marker, consisting of a variable number of CA repeats. This marker
is located within the D5S346 (DP1) region on chromosome 5 and is linked to
the adenomatous polyposis coli gene. Allelic ratios were calculated after
scanning autoradiographs on a densitometer. Ratio values approaching 1 were
observed when the two alleles were close in molecular weight, whereas rati
os less than 1 were detected when the two alleles had very different molecu
lar weights. This discrepancy was more pronounced in paraffin-embedded tiss
ue than with blood samples.
Conclusion: For LOH amplification assays, it is best to use normal control
samples that are of the same tissue source as the neoplastic sample being a
nalyzed. When assessing LOH in neoplastic tissue, a quantitative value rath
er than visual assessment of the alleles should be considered. The values m
ay be normalized by dividing the ratio of the two tumor alleles by the rati
o of the two normal alleles.